"Fraud On FDA" Liability Case Requires Supreme Court Review - MDMA Brief
This article was originally published in The Gray Sheet
Executive Summary
Only the U.S. Supreme Court can resolve conflicts created by lower courts as to whether the Medical Device Amendments of 1976 preempt tort claims, and specifically, "fraud on FDA" claims, the Medical Device Manufacturers Association argues in an amicus brief filed with the high court June 3.